Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Antimicrobial Chemotherapy|March 1, 1991
Clinical effect of BV-araU on varicella-zoster virus infection in immunocompromised patients with haematological malignanciesA Hiraoka, T Masaoka, K Nagai, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 31, 1998
[Remarkable increase of CD8+ CD11a+ and CD8+ CD57- T cells in patients with post-transfusion graft-versus-host disease]T Karasuno, H Nakamura, H Fukuda, et al.
Japanese Journal of Clinical Oncology|August 1, 1994
Recombinant human non-glycosylated granulocyte-macrophage colony-stimulating factor in allogeneic bone marrow transplantation: double-blind placebo-controlled phase III clinical trialA Hiraoka, T Masaoka, H Mizoguchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1997
Cloning, expression, and characterization of a cDNA encoding a novel human growth factor for primitive hematopoietic progenitor cellsA Hiraoka, A Sugimura, T Seki, et al.
Nucleic Acids Symposium Series|January 1, 1997
Synthesis of DHPA analogs and their inhibitory activities of human recombinant S-adenosyl-L-homocysteine hydrolaseY Kitade, M Nakanishi, A Hosoya, et al.
Chemical & Pharmaceutical Bulletin|October 1, 1989
The sennoside constituents of rhei rhizoma and sennae folium as inhibitors of serum monoamine oxidaseA Hiraoka, S Koike, S Sakaguchi, et al.
Bone Marrow Transplantation|August 18, 2001
Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantationA Hiraoka, Y Ohashi, S Okamoto, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|May 1, 1997
[A case of Tsutsugamushi disease as an imported infection]S Ueda, T Yumisashi, K Yoshida, et al.
Journal of Viral Hepatitis|December 17, 2016
Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in JapanH Toyoda, T Tada, K Takaguchi, et al.
Experimental Hematology|September 1, 1989
Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II studyH Teshima, J Ishikawa, H Kitayama, et al.
Pageof 14